Abstract

Information on the different abstract types can be found here

Up to 10 Co-Authors may be added. If there are more than 10 authors, please indicate in the acknowledgement segment below.

Kindly follow the abstract section titles for submission. Please read and accept the Terms and Conditions before final submission.

Theme(s) and Topics

1. WOHC 2022
Topics
One Health Science (OHS): Pandemic Preparedness: detect, prevent and respond: Diagnostic and discovery platforms
One Health Science (OHS): Pandemic Preparedness: detect, prevent and respond: Focus on pandemic prone pathogens
One Health Science (OHS): Pandemic Preparedness: detect, prevent and respond: Sharing of pathogens, resources and data
One Health Science (OHS): Pandemic Preparedness: detect, prevent and respond: Improving outbreak response
One Health Science (OHS): Pandemic Preparedness: detect, prevent and respond: Biosafety and biosecurity for outbreak prevention
One Health Science (OHS): Pandemic Preparedness: detect, prevent and respond: Systems for collecting clinical data
One Health Science (OHS): Risk Factors Driving Zoonotic Infections: Drivers of spillover and reverse zoonosis
One Health Science (OHS): Risk Factors Driving Zoonotic Infections: Clinical, epidemiology and molecular drivers of disease susceptibility
One Health Science (OHS): Risk Factors Driving Zoonotic Infections: Predictive risk models
One Health Science (OHS): Risk Factors Driving Zoonotic Infections: Pathogenesis and modes of transmission
One Health Science (OHS): Risk Factors Driving Zoonotic Infections: Risk assessment of emerging pathogens in animal models
One Health Science (OHS): Risk Factors Driving Zoonotic Infections: Molecular epidemiology and evolution
One Health Science (OHS): Discovery and Surveillance: SARS-CoV-2 and other emerging pathogens
One Health Science (OHS): Discovery and Surveillance: Neglected tropical diseases
One Health Science (OHS): Discovery and Surveillance: Vector borne diseases
One Health Science (OHS): Discovery and Surveillance: Digital-aided events based syndromic and genomics surveillance
One Health Science (OHS): Vaccines and Therapeutics for Emerging Infections: Enabling equitable access
One Health Science (OHS): Vaccines and Therapeutics for Emerging Infections: Novel vaccine technology
One Health Science (OHS): Vaccines and Therapeutics for Emerging Infections: Platforms for universal vaccines and therapeutics
One Health Science (OHS): Vaccines and Therapeutics for Emerging Infections: Veterinary/One Health Vaccines
One Health Science (OHS): Vaccines and Therapeutics for Emerging Infections: Therapeutic antibodies
One Health Science (OHS): Science of Climate and Ecological Change on One Health: Role of climate change in disease emergence
One Health Science (OHS): Science of Climate and Ecological Change on One Health: Intervention and mitigation strategies
One Health Science (OHS): Science of Climate and Ecological Change on One Health: Role of ecological health in One Health
Antimicrobial Resistance (AMR): One Health approach to integrated AMR surveillance: Standardised integrated One Health AMR and Antimicrobial use (AMU)/ Antimicrobial consumption (AMC) surveillance
Antimicrobial Resistance (AMR): One Health approach to integrated AMR surveillance: Environmental AMR monitoring
Antimicrobial Resistance (AMR): AMR interaction and transmission drivers between reservoirs in humans, animals, food and the environment: The impact of human-animal interaction on AMR transmission
Antimicrobial Resistance (AMR): AMR interaction and transmission drivers between reservoirs in humans, animals, food and the environment: Plasmid-mediated resistance
Antimicrobial Resistance (AMR): AMR interaction and transmission drivers between reservoirs in humans, animals, food and the environment: Genomic data linking transmission between the different reservoirs
Policy, Environment & Biosecurity (PEB): Environmental change and health: Environmental change, pathogen risk and health
Policy, Environment & Biosecurity (PEB): Environmental change and health: Policies, interventions and novel approaches (including private sector engagement, advocacy, etc.) to address environmental drivers of disease
Policy, Environment & Biosecurity (PEB): Environmental change and health: Country experience and case studies for integrating environmental perspectives into One Health
Policy, Environment & Biosecurity (PEB): Globalisation and human drivers of disease in a rapidly changing world: Globalisation as a driver of disease risk
Policy, Environment & Biosecurity (PEB): Globalisation and human drivers of disease in a rapidly changing world: Economic activity and One Health risk (ie. land use; domestic animals and wildlife management)
Policy, Environment & Biosecurity (PEB): Globalisation and human drivers of disease in a rapidly changing world: Human, social and ethical dimensions of outbreak preparedness and response efforts (ie. social and economic inequalities, public trust, moveme
Policy, Environment & Biosecurity (PEB): Globalisation and human drivers of disease in a rapidly changing world: Social inequalities and pandemic risk
Policy, Environment & Biosecurity (PEB): Globalisation and human drivers of disease in a rapidly changing world: Biosecurity concerns and One Health
Pandemic Preparedness and Health Systems Resilience (PPHSR): Secondary/indirect impact to human and animal health: Ensuring the fit of key One Health models and innovations and their implementation into health systems.
Pandemic Preparedness and Health Systems Resilience (PPHSR): Secondary/indirect impact to human and animal health: One Health perspectives on bi-directional and indirect impacts on humans and animals
Pandemic Preparedness and Health Systems Resilience (PPHSR): Secondary/indirect impact to human and animal health: Harmonisation of regulatory standards for pandemic response or research
Pandemic Preparedness and Health Systems Resilience (PPHSR): Animal and human vaccines and other preventive interventions for pandemic preparedness: Optimal deployment and new strategies (e.g. oral vaccines) for vaccines
Pandemic Preparedness and Health Systems Resilience (PPHSR): Animal and human vaccines and other preventive interventions for pandemic preparedness: Costs, benefits and risks of animal vaccination: economics of vaccines in relation to antibiot
Pandemic Preparedness and Health Systems Resilience (PPHSR): Animal and human vaccines and other preventive interventions for pandemic preparedness: The impact of global vaccine inequity
Pandemic Preparedness and Health Systems Resilience (PPHSR): Animal and human vaccines and other preventive interventions for pandemic preparedness: The need for transfer of technology and innovations in low resource settings
Impact on and Innovations in Clinical Practice (IICP): Multidrug Resistant Organisms (MDRO) - roles, responsibilities and interests of the non-ID physicians: MDRO in patients with non-communicable diseases
Impact on and Innovations in Clinical Practice (IICP): Multidrug Resistant Organisms (MDRO) - roles, responsibilities and interests of the non-ID physicians: The interdependence of animal and human health - MDRO in pet animals and livestock
Impact on and Innovations in Clinical Practice (IICP): Multidrug Resistant Organisms (MDRO) - roles, responsibilities and interests of the non-ID physicians: Using Clinical Decision Support System (CDSS) to guide antibiotic prescriptions
Impact on and Innovations in Clinical Practice (IICP): Multidrug Resistant Organisms (MDRO) - roles, responsibilities and interests of the non-ID physicians: Use of bioinformatics for the control and containment of infectious diseases
Impact on and Innovations in Clinical Practice (IICP): Multidrug Resistant Organisms (MDRO) - roles, responsibilities and interests of the non-ID physicians: Applying One Health concepts in hospitals to counter MDRO
Impact on and Innovations in Clinical Practice (IICP): Management of Non-Communicable Diseases (NCD) - pivoting during a pandemic and beyond: Chronic NCD management in outbreaks: Leveraging mobile technology to improve patient care
Impact on and Innovations in Clinical Practice (IICP): Management of Non-Communicable Diseases (NCD) - pivoting during a pandemic and beyond: Rethinking NCD care models: Lessons from COVID-19
Impact on and Innovations in Clinical Practice (IICP): Management of Non-Communicable Diseases (NCD) - pivoting during a pandemic and beyond: Impact of the COVID-19 pandemic on NCD care
Policy, Environment & Biosecurity (PEB): Environmental change and health: Policies, interventions and novel approaches (including private sector engagement, advocacy, etc.) to address environmental drivers of disease
Antimicrobial Resistance (AMR): One Health approach to integrated AMR surveillance: Standardised integrated One Health AMR and Antimicrobial use (AMU)/ Antimicrobial consumption (AMC) surveillance
Policy, Environment & Biosecurity (PEB): Globalisation and human drivers of disease in a rapidly changing world: Legal responses to one health and health inequalities
Policy, Environment & Biosecurity (PEB): Globalisation and human drivers of disease in a rapidly changing world: Monitoring One health Determinants
Policy, Environment & Biosecurity (PEB): Science of Climate and Ecological Change of One Health: Climate change and the socio-ecological
Policy, Environment & Biosecurity (PEB): Environmental change and health: Surveillance
Policy, Environment & Biosecurity (PEB): Environmental change and health Strengthening Community Capacity
Policy, Environment & Biosecurity (PEB): Science of Climate and Ecological Change of One Health: Rabies and dog
Policy, Environment & Biosecurity (PEB): Globalisation and human drivers of disease in a rapidly changing world: Biosecurity and zoonotic spill over
Policy, Environment & Biosecurity (PEB): Science of Climate and Ecological Change of One Health: Vector ecology
Antimicrobial Resistance (AMR): Discovery and Surveillance: SARS-CoV-2 and other emerging pathogens
Pandemic Preparedness and Health Systems Resilience (PPHSR): Animal and human vaccines and other preventive interventions for pandemic preparedness: Costs, benefits and risks of animal vaccination
Policy, Environment & Biosecurity (PEB): Science of Climate and Ecological Change of One Health: Conservation and Restoration Ecology
Policy, Environment & Biosecurity (PEB): Environmental change and health: Public and Private policy and practice

View Terms and Conditions

Abstract Submission Terms and Conditions

 

  1. Errors

    • By submitting an abstract to the 7th World One Health Congress (WOHC 2022), the abstract submitter hereby agrees to the following terms and conditions:

      Singapore Health Services Pte Ltd (SingHealth), the Congress Organiser and its Organising Secretariat, Ace:Daytons Direct (International) Pte Ltd, cannot be held responsible for any typing, spelling, or language errors in the submitted abstract(s).

  1. Abstract topic

    • The Scientific/Abstract Committee may decide to allocate the submitted abstract to a different topic than the topic for which it was submitted.

  1. Abstract author consent

    • By submitting an abstract, authors agree that they have received consent from their co-authors to do so.

  1. Abstract author attendance and Publication of the Abstract
    • Upon acceptance of your abstract, the presenting author must register (pay the relevant registration fee) and attend the Congress to present at the Oral Presentation or the Poster Presentation.
    • The abstract will only be published on the Congress website if the presenting author is registered, and full payment will be received by Friday, 30 September 2022, 6:00 pm SGT.
    • No changes to accepted abstracts will be allowed.
  2. Final decision on abstracts
    • An abstract review committee will review the abstracts, with the final decision being made by the committee. Abstract evaluation will be merit based.
    • The Scientific / Abstract Committee's decision on the abstract is final, and no further correspondence on the status of the abstract will be entertained.
  3. Copyright
    • The authors grant SingHealth, the WOHC 2022 Organiser, the right to publish, reproduce, distribute, display, and store the abstract (submitted text only), together with author names and biographies where supplied in different formats, including print, electronic and digital forms (including on the WOHC 2022 website).
    • The abstract author agrees and understands that SingHealth takes no responsibility for registering any copyright on behalf of the abstract author/s. Authors hereby accept and confirm that their abstract contains no text for reference that is either directly or indirectly defamatory or is otherwise unlawful, invades individual privacy, or infringes on any proprietary right or statutory copyright.
    • By submitting an abstract to WOHC 2022, authors affirm that their abstract is their original work, or they have obtained permission at their own expense from the copyright holder (of all data and/or text) for publication. The authors, upon request, will submit signed documentation showing permission for use to SingHealth.
    • Authors understand that the information contained in their submitted abstract may be shared with third-party processors such as graphic designers and printing services for the express purpose of printing or uploading the congress abstract book according to the license as stated above.
  4. Commercial Interest

    • The author(s) must declare to the WOHC 2022 Scientific /Abstract Committee if they have any commercial interests or associations that might conflict with their submission. If accepted for presentation, the commercial interest or association must be declared on the title slide (for oral presentations) or at the bottom of the poster (for poster presentations). All presentations should include funding and other acknowledgements where applicable.

  1. Photography and Videography

    • The author(s) give SingHealth and its Organising Secretariat permission to take photographs and videos of their presentation at the Congress, which may be used on the WOHC 2022 website and other WOHC 2022 social media.

  1. Withdrawal policy

    • If the abstract presenter wishes to withdraw their abstract, they must do by Friday, 30 September 2022. After this date, the WOHC 2022 Organising Secretariat cannot guarantee that the abstract will be removed from the printed/physical Conference Abstract Book (if applicable).

  1. Communications

    • All communications regarding this abstract will be directed to the abstract submitter. It is the responsibility of the abstract submitter to inform the co-authors of the abstract acceptance status.

  1. Indemnification

    • Authors agree to indemnify and hold harmless SingHealth, its agents, and representatives should the material presented or provided for publication be determined to defame, libel, or slander an individual or organisation, violate the confidentiality of any individual or organisation, or infringe on another's copyright.

  1. Presenter to take care of all charges

    • Acceptance of an abstract does not imply the provision of travel, accommodation, or registration for the Congress, any other cost associated with preparation or presentation of the abstract, or any cost associated with attendance at the congress.